Rep. DeLauro’s FDA Plans: “Restore Oversight,” Increase Budget
This article was originally published in The Gray Sheet
Executive Summary
Rep. Rosa DeLauro (D-Conn.), expected to chair the House panel overseeing FDA's budget, wants to increase agency funding, but not without the caveat of enhanced congressional oversight